| Literature DB >> 29692648 |
Ming-San Miao1, Meng-Fan Peng1, Rui-Juan Ma1, Ming Bai1, Bao-Song Liu1.
Abstract
Objective: To study the effects of the different components of the total flavonoids and total saponins from Mao Dongqing's active site on the rats of TIA model, determine the optimal reactive components ratio of Mao Dongqing on the rats of TIA.Entities:
Keywords: Mao Dongqing'stotal flavonoids; Optimal active ratio components; TIA animal model; Total saponins
Year: 2017 PMID: 29692648 PMCID: PMC5911644 DOI: 10.1016/j.sjbs.2017.10.011
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 1319-562X Impact factor: 4.219
The effect of behavioral score of TIA rats ( ± s).
| Group | Dose (g/kg) | Number | First score | Number | Second score | Mortality (%) |
|---|---|---|---|---|---|---|
| Blank | – | 20 | 0 ± 0 | 20 | 0 ± 0 | 0% |
| Model | – | 14 | 2.9 ± 0.6 | 9 | 2.7 ± 0.5 | 55% |
| Nimodipine | 0.02 | 14 | 1.7 ± 1.0 | 11 | 1.5 ± 0.9 | 45% |
| Yangxueqingnaokeli | 1 | 15 | 1.7 ± 1.0 | 10 | 1.5 ± 0.7 | 50% |
| 10:5 high dose | Total flavonoids: total flavonoids = 0.133:0.067 | 15 | 1.5 ± 1.0 | 11 | 1.7 ± 1.0 | 45% |
| 10:5 middle dose | Total flavonoids: total flavonoids = 0.067:0.033 | 14 | 1.9 ± 0.9 | 10 | 1.5 ± 0.7 | 50% |
| 10:5 low dose | Total flavonoids: total flavonoids = 0.033:0.017 | 15 | 2.4 ± 0.6 | 10 | 2.3 ± 0.7 | 50% |
| 10:6high dose | Total flavonoids: total flavonoids = 0.125:0.075 | 15 | 1.4 ± 0.9 | 10 | 1.5 ± 0.9 | 50% |
| 10:6 middle dose | Total flavonoids: total flavonoids = 0.0625:0.0375 | 15 | 1.9 ± 0.9 | 10 | 1.8 ± 0.9 | 50% |
| 10:6 low dose | Total flavonoids: total flavonoids = 0.003:0.002 | 15 | 3.6 ± 5.1 | 10 | 1.9 ± 0.9 | 50% |
| 10:7 high dose | Total flavonoids: total flavonoids = 0.118:0.082 | 15 | 1.6 ± 0.9 | 10 | 1.6 ± 0.8 | 50% |
| 10:7 middle dose | Total flavonoids: total flavonoids = 0.058:0.042 | 15 | 1.9 ± 0.8 | 10 | 1.6 ± 0.7 | 50% |
| 10:7 low dose | Total flavonoids: total flavonoids = 0.029:0.021 | 14 | 1.9 ± 1.8 | 9 | 2.3 ± 0.7 | 45% |
Compared with model group P < 0.05.
Compared with model group P < 0.01.
Effect of SGA (serum glutamic acid) content in TIA model rats ( ± s).
| Group | Number | Dose (g/kg) | SGA (μmol/L) |
|---|---|---|---|
| Blank | 20 | – | 115.734 ± 26.930 |
| Model | 9 | – | 202.325 ± 52.413 |
| Nimodipine | 11 | 0.02 | 127.641 ± 50.894 |
| Yangxueqingnaokeli | 10 | 1 | 142.407 ± 41.004 |
| 10:5 high dose | 11 | Total flavonoids: total flavonoids = 0.133:0.067 | 130.358 ± 28.634 |
| 10:5 middle dose | 10 | Total flavonoids: total flavonoids = 0.067:0.033 | 157.177 ± 73.956 |
| 10:5low dose | 10 | Total flavonoids: total flavonoids = 0.033:0.017 | 204.882 ± 60.374 |
| 10:6 high dose | 10 | Total flavonoids: total flavonoids = 0.125:0.075 | 118.373 ± 41.313 |
| 10:6 middle dose | 10 | Total flavonoids: total flavonoids = 0.0625:0.0375 | 149.070 ± 31.280 |
| 10:6 low dose | 10 | Total flavonoids: total flavonoids = 0.003:0.002 | 185.101 ± 64.120 |
| 10:7 high dose | 10 | Total flavonoids: total flavonoids = 0.118:0.082 | 132.560 ± 33.391 |
| 10:7 middle dose | 10 | Total flavonoids: total flavonoids = 0.058:0.042 | 140.229 ± 28.051 |
| 10:7 low dose | 9 | Total flavonoids: total flavonoids = 0.029:0.021 | 181.802 ± 41.370 |
Compared with model group P < 0.05.
Compared with model group P < 0.01.
The effects of plasma LPA level in rats with TIA ( ± s).
| Group | Number | Dose (g/kg) | LPA (μmol/L) |
|---|---|---|---|
| Blank | 20 | – | 732.5 ± 66.4 |
| Model | 9 | – | 910.0 ± 35.7 |
| Nimodipine | 11 | 0.02 | 713.9 ± 238.7 |
| Yangxueqingnaokeli | 10 | 1 | 755.0 ± 41.2 |
| 10:5 high dose | 11 | Total flavonoids: total flavonoids = 0.133:0.067 | 732.0 ± 206.6 |
| 10:5 middle dose | 10 | Total flavonoids: total flavonoids = 0.067:0.033 | 820.0 ± 21.1 |
| 10:5 low dose | 10 | Total flavonoids: total flavonoids = 0.033:0.017 | 848.0 ± 29.4 |
| 10:6 high dose | 10 | Total flavonoids: total flavonoids = 0.125:0.075 | 755.0 ± 61.9 |
| 10:6 middle dose | 10 | Total flavonoids: total flavonoids = 0.0625:0.0375 | 786.0 ± 38.6 |
| 10:6 low dose | 10 | Total flavonoids: total flavonoids = 0.003:0.002 | 827.0 ± 22.6 |
| 10:7 high dose | 10 | Total flavonoids: total flavonoids = 0.118:0.082 | 795.0 ± 28.8 |
| 10:7 middle dose | 10 | Total flavonoids: total flavonoids = 0.058:0.042 | 817.0 ± 27.5 |
| 10:7 low dose | 9 | Total flavonoids: total flavonoids = 0.029:0.021 | 831.1 ± 22.0 |
Compared with model group P < 0.05.
Compared with model group P < 0.01.
The effect on the activity of brain tissue Na+-K+-ATP enzyme, Ca++-ATP enzyme and Mg++-ATP enzyme ( ± s).
| Group | Number | Dose (g/kg) | Ca++-ATP enzyme (μmolPi/mgprot/h) | Mg++-ATP (μmolPi/mgprot/h) | Na+-K+-ATP (μmolPi/mgprot/h) |
|---|---|---|---|---|---|
| Blank | 20 | – | 6.752 ± 1.131 | 5.031 ± 0.701 | 7.210 ± 1.476 |
| Model | 9 | – | 2.917 ± 0.385 | 2.699 ± 0.732 | 4.382 ± 0.698 |
| Nimodipine | 11 | 0.02 | 5.114 ± 1.486 | 4.315 ± 1.079 | 6.535 ± 1.460 |
| Yangxueqingnaokeli | 10 | 1 | 5.504 ± 0.908 | 4.714 ± 0.639 | 6.851 ± 0.820 |
| 10:5 high dose | 11 | Total flavonoids: total flavonoids = 0.133:0.067 | 6.251 ± 1.227 | 5.037 ± 0.616 | 7.203 ± 0.878 |
| 10:5 middle dose | 10 | Total flavonoids: total flavonoids = 0.067:0.033 | 5.373 ± 0.551 | 4.129 ± 0.335 | 6.358 ± 0.564 |
| 10:5 low dose | 10 | Total flavonoids: total flavonoids = 0.033:0.017 | 3.235 ± 0.328 | 3.261 ± 0.630 | 5.588 ± 0.622 |
| 10:6 high dose | 10 | Total flavonoids: total flavonoids = 0.125:0.075 | 6.653 ± 1.018 | 5.161 ± 0.788 | 7.396 ± 0.726 |
| 10:6 middle dose | 10 | Total flavonoids: total flavonoids = 0.0625:0.0375 | 5.450 ± 0.692 | 4.460 ± 0.629 | 6.711 ± 1.042 |
| 10:6 low dose | 10 | Total flavonoids: total flavonoids = 0.003:0.002 | 3.357 ± 0.900 | 3.390 ± 0.385 | 5.884 ± 0.622 |
| 10:7 high dose | 10 | Total flavonoids: total flavonoids = 0.118:0.082 | 6.305 ± 1.018 | 5.002 ± 0.241 | 7.205 ± 0.664 |
| 10:7 middle dose | 10 | Total flavonoids: total flavonoids = 0.058:0.042 | 5.346 ± 0.497 | 4.006 ± 0.454 | 6.399 ± 0.642 |
| 10:7 small dose | 9 | Total flavonoids: total flavonoids = 0.029:0.021 | 3.224 ± 0.629 | 3.244 ± 0.826 | 5.278 ± 0.773 |
Compared with model group P < 0.05.
Compared with model group P < 0.01.
The effect of pathological changes in the hippocampus of rats with TIA.
| Group | Number | Dose (g/kg) | − | + | ++ | +++ |
|---|---|---|---|---|---|---|
| Blank | 16 | – | 16 | 0 | 0 | 0 |
| Model | 10 | – | 0 | 0 | 0 | 10 |
| Nimodipine | 15 | 0.04 | 15 | 0 | 0 | 0 |
| Yangxueqingnao | 12 | 2 | 6 | 6 | 0 | 0 |
| 10:5 high dose | 13 | Total flavonoids: total flavonoids = 0.2:0.1 | 12 | 1 | 0 | 0 |
| 10:5 middle dose | 11 | Total flavonoids: total flavonoids = 0.1:0.05 | 9 | 2 | 0 | 0 |
| 10:5 low dose | 11 | Total flavonoids: total flavonoids = 0.05:0.025 | 2 | 4 | 5 | 0 |
| 10:6 high dose | 13 | Total flavonoids: total flavonoids = 0.19:0.11 | 13 | 0 | 0 | 0 |
| 10:6 middle dose | 12 | Total flavonoids: total flavonoids = 0.094:0.056 | 10 | 2 | 0 | 0 |
| 10:6low dose | 11 | Total flavonoids: total flavonoids = 0.047:0.028 | 3 | 4 | 4 | 0 |
| 10:7 high dose | 11 | Total flavonoids: total flavonoids = 0.18:0.12 | 11 | 0 | 0 | 0 |
| 10:7 middle dose | 12 | Total flavonoids: total flavonoids = 0.088:0.062 | 9 | 3 | 0 | 0 |
| 10:7 low dose | 11 | Total flavonoids: total flavonoids = 0.044:0.031 | 0 | 6 | 5 | 0 |
“−” No abnormal changes were found in the brain nerve cells; “+” A small number of nerve cells atrophy; “++” Some nerve cell atrophy and cell cytoplasm decrease; “+++” Most of the nerve cells were significantly decreased or the cytoplasm was significantly decreased.
Fig. 1The effect of pathological changes in the hippocampus of rats.
The effects of pathological changes in the cerebral cortex of rats with TIA.
| Group | Number | Dose (g/kg) | − | + | ++ | +++ |
|---|---|---|---|---|---|---|
| Blank | 16 | – | 16 | 0 | 0 | 0 |
| Model | 10 | – | 0 | 0 | 1 | 9 |
| Nimodipine | 15 | 0.04 | 14 | 1 | 0 | 0 |
| Yangxueqingnaokeli | 12 | 2 | 0 | 0 | 4 | 8 |
| 10:5 high dose | 13 | Total flavonoids: total flavonoids = 0.2:0.1 | 2 | 3 | 7 | 0 |
| 10:5 middle dose | 11 | Total flavonoids: total flavonoids = 0.1:0.05 | 2 | 4 | 5 | 0 |
| 10:5 low dose | 11 | Total flavonoids: total flavonoids = 0.05:0.025 | 0 | 1 | 2 | 8 |
| 10:6 high dose | 13 | Total flavonoids: total flavonoids = 0.19:0.11 | 5 | 2 | 6 | 0 |
| 10:6 middle dose | 12 | Total flavonoids: total flavonoids = 0.094:0.056 | 10 | 2 | 0 | 0 |
| 10:6 low dose | 11 | Total flavonoids: total flavonoids = 0.047:0.028 | 4 | 6 | 1 | 0 |
| 10:7 high dose | 11 | Total flavonoids: total flavonoids = 0.18:0.12 | 3 | 7 | 1 | 0 |
| 10:7 middle dose | 12 | Total flavonoids: total flavonoids = 0.088:0.062 | 2 | 3 | 7 | 1 |
| 10:7 low dose | 11 | Total flavonoids: total flavonoids = 0.044:0.031 | 1 | 2 | 6 | 2 |
“−” the cerebral cortex nerve cells were basically normal; “+” individual of the cerebral cortex nerve cells were edema ; “++” the cerebral cortex nerve cells were partial edema; “+++” most of the cerebral cortex nerve cells were edema.
Fig. 2The effects of pathological changes in the cerebral cortex of rats with TIA.
Index improvement rate classification results.
| Rat improvement rate classification criteria | ||||
|---|---|---|---|---|
| Grade | Significant improvement | Improved | Slight improvement | No improvement |
| Large dose group | >80% | 80–50% | 50–20% | <20% |
| Middle dose group | 30%< | 30–20% | 20–5% | <5% |
| Low dose group | 20%< | 20–10% | 10–5% | <5% |
| Weight coefficient | 0.4 | 0.3 | 0.2 | 0.1 |
The comparison of the efficacy of the same dose of total flavonoids and total saponin 10:5, 10:6, 10:7 of Mao Dongqing.
| Core index | Relevant index | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Group | Behavioral score | Hippocampal area | Cortical area | LPA | Na+-K+-ATP | Mg++-ATP | Ca++-ATP | Glutamic acid | P value |
| 10:5 Low dose | ++ | +++ | ++ | ++ | ++ | ++ | ++ | – | 1 |
| 10:6 Low dose | +++ | +++ | +++ | +++ | +++ | ++ | ++ | ++ | 1.51 |
| 10:7 Low dose | ++ | +++ | ++ | +++ | ++ | ++ | ++ | +++ | 1.27 |
| 10:5 Middle dose | +++ | +++ | +++ | ++ | ++ | ++ | +++ | ++ | 1.44 |
| 10:6 Middle dose | ++ | +++ | +++ | +++ | +++ | +++ | +++ | ++ | 1.5 |
| 10:7 Middle dose | ++ | +++ | +++ | +++ | ++ | ++ | +++ | +++ | 1.44 |
| 10:5 Large dose | ++ | +++ | +++ | ++ | ++ | ++ | +++ | +++ | 1.4 |
| 10:6 Large dose | ++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | 1.53 |
| 10:7 Large dose | ++ | +++ | +++ | ++ | ++ | ++ | +++ | ||
| ++ | 1.37 | ||||||||
P = I level index score * I level index weight coefficient + II level index score * II index weight coefficient = (m * 0.4 + n * 0.3 + p * 0.2 + q * 0.1) * 0.7 + (m * 0.4 + n * 0.3 + p * 0.2 + q * 0.1) * 0.3 (m: the number of +++; n: the number of++; p: the number of +; q: the number of −; +++: improve significantly; ++: improve; +: improve slightly; –: no improve).
Results of index classification.
| Category | I level index (core index) | II level indicators (related indicators) |
|---|---|---|
| Index | Behavioral score and pathological findings | ATP, glutamic acid |
| Weight coefficient | 0.7 | 0.3 |